These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 9404370)

  • 1. Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.
    Lipworth BJ; Clark DJ; Koch P; Arbeeny C
    Thorax; 1997 Oct; 52(10):849-52. PubMed ID: 9404370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of cumulative single doses of inhaled salbutamol enantiomers in asthmatic subjects.
    Gumbhir-Shah K; Kellerman DJ; DeGraw S; Koch P; Jusko WJ
    Pulm Pharmacol Ther; 1999; 12(6):353-62. PubMed ID: 10587476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine.
    Cockcroft DW; Swystun VA
    Thorax; 1997 Oct; 52(10):845-8. PubMed ID: 9404369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance to the bronchoprotective effect of beta2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo.
    Cockcroft DW; Davis BE; Swystun VA; Marciniuk DD
    J Allergy Clin Immunol; 1999 Jun; 103(6):1049-53. PubMed ID: 10359885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.
    Lipworth BJ; Newnham DM; Clark RA; Dhillon DP; Winter JH; McDevitt DG
    Thorax; 1995 Jan; 50(1):54-61. PubMed ID: 7886650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant inhaled corticosteroid resensitises cardiac beta2-adrenoceptors in the presence of long-acting beta2-agonist therapy.
    Aziz I; McFarlane LC; Lipworth BJ
    Eur J Clin Pharmacol; 1998 Jul; 54(5):377-81. PubMed ID: 9754979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of airway calibre on lung delivery of nebulised salbutamol.
    Lipworth BJ; Clark DJ
    Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-isomer R-salbutamol is not superior to racemate regarding protection for bronchial hyperresponsiveness.
    Sjöswärd KN; Hmani M; Davidsson A; Söderkvist P; Schmekel B
    Respir Med; 2004 Oct; 98(10):990-9. PubMed ID: 15481276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade.
    Lipworth BJ; Brown RA; McDevitt DG
    Br J Clin Pharmacol; 1989 Jul; 28(1):95-102. PubMed ID: 2570601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of levosalbutamol: what are the clinical implications?
    Boulton DW; Fawcett JP
    Clin Pharmacokinet; 2001 Jan; 40(1):23-40. PubMed ID: 11236808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and systemic beta2-adrenoceptor-mediated responses to inhaled salbutamol.
    Fowler SJ; Lipworth BJ
    Br J Clin Pharmacol; 2001 Apr; 51(4):359-62. PubMed ID: 11318774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic characteristics and safety of inhaled albuterol enantiomers in healthy volunteers.
    Gumbhir-Shah K; Kellerman DJ; DeGraw S; Koch P; Jusko WJ
    J Clin Pharmacol; 1998 Dec; 38(12):1096-106. PubMed ID: 11301561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
    Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
    Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients.
    Lötvall J; Palmqvist M; Arvidsson P; Maloney A; Ventresca GP; Ward J
    J Allergy Clin Immunol; 2001 Nov; 108(5):726-31. PubMed ID: 11692096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects.
    Bennett JA; Tattersfield AE
    Thorax; 1997 May; 52(5):458-64. PubMed ID: 9176539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levalbuterol hydrochloride.
    Handley DA; Morley J; Vaickus L
    Expert Opin Investig Drugs; 1998 Dec; 7(12):2027-41. PubMed ID: 15991945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preserved bronchial dilatation after salbutamol does not guarantee protection against bronchial hyperresponsiveness.
    Sjöswärd KN; Josefsson M; Ahlner J; Schmekel B
    Clin Physiol Funct Imaging; 2003 Jan; 23(1):14-20. PubMed ID: 12558609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma.
    Lipworth BJ; Clark RA; Dhillon DP; Brown RA; McDevitt DG
    Br J Clin Pharmacol; 1988 Nov; 26(5):527-33. PubMed ID: 2849969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metered dose inhaler salbutamol treatment of asthma in the ED: comparison of two doses with plasma levels.
    Rodrigo G; Rodrigo C
    Am J Emerg Med; 1996 Mar; 14(2):144-50. PubMed ID: 8924135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.